Format
Sort by
Items per page

Send to

Choose Destination

Best matches for "idiopathic pulmonary fibrosis":

Idiopathic pulmonary fibrosis. Richeldi L et al. Lancet. (2017)

Idiopathic pulmonary fibrosis. King TE Jr et al. Lancet. (2011)

Idiopathic pulmonary fibrosis: evolving concepts. Ryu JH et al. Mayo Clin Proc. (2014)

Search results

Items: 1 to 20 of 7407

1.

Telomeres in Interstitial Lung Disease: The Short and the Long of It.

Courtwright AM, El-Chemaly S.

Ann Am Thorac Soc. 2018 Dec 12. doi: 10.1513/AnnalsATS.201808-508CME. [Epub ahead of print]

PMID:
30540921
2.

Another Weapon in the Battle Against Idiopathic Pulmonary Fibrosis?

Wilson CL, Hung CF.

Am J Respir Cell Mol Biol. 2018 Dec 12. doi: 10.1165/rcmb.2018-0387ED. [Epub ahead of print] No abstract available.

PMID:
30540914
3.

The Tyrosine Kinase Inhibitor TAS-115 Attenuates Bleomycin-Induced Lung Fibrosis in Mice.

Koyama K, Goto H, Morizumi S, Kagawa K, Nishimura H, Sato S, Kawano H, Toyoda Y, Ogawa H, Homma S, Nishioka Y.

Am J Respir Cell Mol Biol. 2018 Dec 12. doi: 10.1165/rcmb.2018-0098OC. [Epub ahead of print]

PMID:
30540913
4.

The Antifibrotic Activity of Prostacyclin Receptor Agonism is Mediated through Inhibition of YAP/TAZ.

Zmajkovicova K, Menyhart K, Bauer Y, Studer R, Renault B, Schnoebelen M, Bolinger M, Nayler O, Gatfield J.

Am J Respir Cell Mol Biol. 2018 Dec 11. doi: 10.1165/rcmb.2018-0142OC. [Epub ahead of print]

PMID:
30537446
5.

A novel biomarker of serum Histidine-Rich Glycoprotein (HRG) for diagnosing and predicting prognosis of ventilator-associated pneumonia (VAP): a pilot study.

Ding HG, Zhou HF, Diao MY, Xu Y, Pan QM, Shen XH.

Eur Rev Med Pharmacol Sci. 2018 Nov;22(22):7920-7927. doi: 10.26355/eurrev_201811_16419.

PMID:
30536339
6.

Small-animal SPECT/CT imaging of cancer xenografts and pulmonary fibrosis using a 99mTc-labeled integrin αvβ6-targeting cyclic peptide with improved in vivo stability.

Liu H, Gao L, Yu X, Zhong L, Shi J, Jia B, Li N, Liu Z, Wang F.

Biophys Rep. 2018;4(5):254-264. doi: 10.1007/s41048-018-0071-1. Epub 2018 Nov 2.

PMID:
30533490
7.

A successful treatment of rheumatoid arthritis-related interstitial pneumonia with nintedanib.

Kakuwa T, Izumi S, Sakamoto K, Suzuki T, Iikura M, Sugiyama H.

Respir Med Case Rep. 2018 Nov 1;26:50-52. doi: 10.1016/j.rmcr.2018.10.026. eCollection 2019.

8.

Accelerated aging induced by deficiency of Zmpste24 protects old mice to develop bleomycin-induced pulmonary fibrosis.

Calyeca J, Balderas-Martínez YI, Olmos R, Jasso R, Maldonado V, Rivera Q, Selman M, Pardo A.

Aging (Albany NY). 2018 Dec 10. doi: 10.18632/aging.101679. [Epub ahead of print]

9.

Corrigendum to 'Synthesis and discovery of a drug candidate for treatment of idiopathic pulmonary fibrosis through inhibition of TGF-b1 pathway' [Eur. J. Med. Chem. 157 (2018) 229-247].

Li X, Lu C, Liu S, Liu S, Su C, Xiao T, Bi Z, Sheng P, Huang M, Liu X, Wei Y, Zhao L, Miao S, Mao J, Huang K, Gao S, Liu N, Qi M, Liu T, Qin S, Wei L, Sun T, Ning W, Yang G, Zhou H, Yang C.

Eur J Med Chem. 2018 Dec 7;163:403. doi: 10.1016/j.ejmech.2018.11.071. [Epub ahead of print] No abstract available.

PMID:
30530191
10.

Minimally invasive open-window thoracostomy using wound edge protectors.

Shimizu K, Ohtaki Y, Nakazawa S, Obayashi K, Nagashima T, Yajima T, Mogi A, Shirabe K.

Ann Thorac Surg. 2018 Dec 5. pii: S0003-4975(18)31783-1. doi: 10.1016/j.athoracsur.2018.10.064. [Epub ahead of print]

PMID:
30529214
11.

lncITPF Promotes Pulmonary Fibrosis by Targeting hnRNP-L Depending on Its Host Gene ITGBL1.

Song X, Xu P, Meng C, Song C, Blackwell TS, Li R, Li H, Zhang J, Lv C.

Mol Ther. 2018 Sep 6. pii: S1525-0016(18)30441-6. doi: 10.1016/j.ymthe.2018.08.026. [Epub ahead of print]

PMID:
30528088
12.

Neutralization of IL-18 by IL-18 binding protein ameliorates bleomycin-induced pulmonary fibrosis via inhibition of epithelial-mesenchymal transition.

Zhang LM, Zhang Y, Fei C, Zhang J, Wang L, Yi ZW, Gao G.

Biochem Biophys Res Commun. 2018 Dec 4. pii: S0006-291X(18)32561-0. doi: 10.1016/j.bbrc.2018.11.129. [Epub ahead of print]

PMID:
30527805
13.

Single Versus Bilateral Lung Transplantation for Idiopathic Pulmonary Fibrosis in the Lung Allocation Score Era.

Spratt JR, Tomic R, Brown RZ, Rudser K, Loor G, Hertz M, Shumway S, Kelly RF.

J Surg Res. 2019 Feb;234:84-95. doi: 10.1016/j.jss.2018.08.054. Epub 2018 Oct 5.

PMID:
30527505
14.

Characterization of the tumor immune-microenvironment of lung adenocarcinoma associated with usual interstitial pneumonia.

Ueda T, Aokage K, Mimaki S, Tane K, Miyoshi T, Sugano M, Kojima M, Fujii S, Kuwata T, Ochiai A, Kusumoto M, Suzuki K, Tsuchihara K, Nishikawa H, Goto K, Tsuboi M, Ishii G.

Lung Cancer. 2018 Dec;126:162-169. doi: 10.1016/j.lungcan.2018.11.006. Epub 2018 Nov 6.

PMID:
30527182
15.

Idiopathic Pulmonary Fibrosis: Prospective, Case-Controlled Study of Natural History and Circulating Biomarkers.

Raghu G, Richeldi L, Jagerschmidt A, Martin V, Subramaniam A, Ozoux ML, Esperet CA, Soubrane C.

Chest. 2018 Dec;154(6):1359-1370. doi: 10.1016/j.chest.2018.08.1083.

PMID:
30526970
16.

Existing and emerging biomarkers for disease progression in idiopathic pulmonary fibrosis.

Inchingolo R, Varone F, Sgalla G, Richeldi L.

Expert Rev Respir Med. 2018 Dec 7. doi: 10.1080/17476348.2019.1553620. [Epub ahead of print]

PMID:
30526140
17.

Assessment of survival in patients with idiopathic pulmonary fibrosis using quantitative HRCT indexes.

Torrisi SE, Palmucci S, Stefano A, Russo G, Torcitto AG, Falsaperla D, Gioè M, Pavone M, Vancheri A, Sambataro G, Sambataro D, Mauro LA, Grassedonio E, Basile A, Vancheri C.

Multidiscip Respir Med. 2018 Dec 1;13:43. doi: 10.1186/s40248-018-0155-2. eCollection 2018.

18.

[Diagnosis and Treatment of Interstitial Lung Diseases].

Jakubczyc A, Neurohr C.

Dtsch Med Wochenschr. 2018 Dec;143(24):1774-1777. doi: 10.1055/a-0622-9299. Epub 2018 Dec 3. German.

PMID:
30508858
19.

Integrative analyses of genes associated with idiopathic pulmonary fibrosis.

Wang H, Xie Q, Ou-Yang W, Zhang M.

J Cell Biochem. 2018 Dec 2. doi: 10.1002/jcb.28153. [Epub ahead of print]

PMID:
30506760
20.

Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study.

Wijsenbeek M, Bendstrup E, Valenzuela C, Henry MT, Moor C, Bengus M, Perjesi A, Gilberg F, Kirchgaessler KU, Vancheri C.

Adv Ther. 2018 Nov 30. doi: 10.1007/s12325-018-0845-3. [Epub ahead of print]

PMID:
30506309

Supplemental Content

Loading ...
Support Center